In last trading session, Nuvectis Pharma Inc (NASDAQ:NVCT) saw 0.35 million shares changing hands with its beta currently measuring 0.44. Company’s recent per share price level of $10.81 trading at $2.47 or 29.62% at ring of the bell on the day assigns it a market valuation of $208.86M. That closing price of NVCT’s stock is at a discount of -11.93% from its 52-week high price of $12.10 and is indicating a premium of 45.88% from its 52-week low price of $5.85. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.16 million shares which gives us an average trading volume of 124.98K if we extend that period to 3-months.

Nuvectis Pharma Inc (NASDAQ:NVCT) trade information

Nuvectis Pharma Inc’s shares saw a change of 29.62% in year-to-date performance and have moved 68.64% in past 5-day. Nuvectis Pharma Inc (NASDAQ:NVCT) showed a performance of 74.64% in past 30-days. Number of shares sold short was 1.05 million shares which calculate 11.5 days to cover the short interests.

Nuvectis Pharma Inc (NVCT) estimates and forecasts

Statistics highlight that Nuvectis Pharma Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 68.91% of value to its shares in past 6 months, showing an annual growth rate of 27.27% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Nuvectis Pharma Inc (NASDAQ:NVCT)’s Major holders

Insiders are in possession of 51.42% of company’s total shares while institution are holding 8.16 percent of that, with stock having share float percentage of 16.80%. Investors also watch the number of corporate investors in a company very closely, which is 8.16% institutions for Nuvectis Pharma Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at NVCT for having 0.25 million shares of worth $1.59 million. And as of 2024-06-30, it was holding 1.5166 of the company’s outstanding shares.

The second largest institutional holder is BALDWIN BROTHERS LLC/MA, which was holding about 0.17 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.0183 of outstanding shares, having a total worth of $1.07 million.